Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Andreani partners with Swiss family office to launch new quant managed account

Tuesday, January 17, 2012

Benedicte Gravrand, Opalesque Geneva:

Alexandre M. Andreani, CEO/CIO of Andreani & Associés, has started a strategic partnership with a family office based in Switzerland (near Geneva), specialized in quantitative systematic programs. "Our collaboration started last autumn and entailed several months of due diligence," he said in an announcement.

In that partnership, Andreani will implement and develop quantitative models and find investors, and the family office will seed the new programs. He supplied these models to several single manager hedge funds during his more than 10 years of experience in research and development of quantitative trading models.

The partnership is based on the new Klimen II Intraday Managed Futures, a fully automated and systematic computer driven program that trades intraday, collecting data on a minute by minute basis with high-speed data storage and order routing engine, where human intervention is merely limited to the supervision of the correct functioning of the program.

"Our trading platform, developed in-house, handles maintenance, development, real-time trading and daily risk management thanks to our high-level technological infrastructure," he noted.

Net of all costs, the Klimen II Intraday program was up 19.2%( paper trading) in 2011, versus the Lyxor CTA Short Term Tracker 2.72%, Lyxor CTA Long Term Tracker -5.67%, Newedge Short Term Traders Index of -3.72% and the Barclays Systematic Traders Index of -3.79%.

And......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its